Biogen | BIIB - EPS Earnings Per Share

Stock Price
179.89
Daily Change
3.71 2.11%
Monthly
2.22%
Yearly
24.98%
Q1 Forecast
174.35

Biogen reported $4.81 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 1.74 3.44 Feb/06 2026
FY2025Q3 Sep/2025 4.81 3.84 4.08 Oct/30 2025
FY2025Q2 Jun/2025 5.47 4.08 5.28 Jul/31 2025
FY2025Q1 Mar/2025 3.02 3.96 3.67 May/01 2025
FY2024Q4 Dec/2024 3.44 3.41 2.95 Feb/12 2025




Eps Change Date
AbbVie USD 1.86 1.11 Sep/2025
Acadia Pharmaceuticals USD 0.42 0.26 Sep/2025
ALKERMES USD 0.49 0.03 Sep/2025
Amgen USD 5.64 0.38 Sep/2025
Bayer EUR 0.57 0.66 Sep/2025
Biogen USD 4.81 0.66 Sep/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Bristol-Myers Squibb USD 1.63 0.17 Sep/2025
Eli Lilly USD 7.02 0.71 Sep/2025
Gilead Sciences USD 2.47 0.46 Sep/2025
Incyte USD 2.26 0.69 Sep/2025
Merck USD 2.58 0.45 Sep/2025
Moderna USD -0.51 1.62 Sep/2025
Neurocrine Biosciences USD 2.17 0.52 Sep/2025
Novartis USD 2.04 0.38 Sep/2025
Pfizer USD 0.87 0.09 Sep/2025
PTC Therapeutics USD 0.2 1.03 Sep/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025
Sanofi EUR -0.67 3.62 Dec/2025
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
Teva Pharmaceutical Industries USD 2.98 0.43 Dec/2025
Ultragenyx Pharmaceutical USD -1.81 0.64 Sep/2025
United Therapeutics USD 7.16 0.75 Sep/2025
Vertex Pharmaceuticals USD 4.8 0.28 Sep/2025